Latest news with #MKSInstruments
Wall Street Journal
3 days ago
- Business
- Wall Street Journal
Lawmakers Traded Stocks Heavily as Trump Rolled Out ‘Liberation Day' Tariffs
WASHINGTON—As markets tanked in the wake of President Trump's 'Liberation Day' tariffs in early April, members of Congress and their families made hundreds of stock trades, shining a spotlight on a controversial practice that some lawmakers have pushed to ban. From April 2, when Trump launched sweeping tariffs to April 8, the day before he paused many of them, more than a dozen House lawmakers and their family members made more than 700 stock trades, according to a Wall Street Journal analysis of disclosure filings. Top stocks purchased in that 'liberation week' period, by the number of trades listed in the disclosures, included MKS Instruments Inc. and JP Morgan Chase, while the most sold stocks included Honeywell and Visa.
Yahoo
7 days ago
- Business
- Yahoo
Top Technology Executives Recognized at the 2025 BostonCIO ORBIE Awards
Leading CIOs honored for leadership, innovation, and business impact BOSTON, June 06, 2025 (GLOBE NEWSWIRE) -- The 2025 BostonCIO ORBIE Awards recognized the exceptional leadership and innovation of top technology executives from Bose Corporation, Merck & Co., Inc., MKS Instruments, Inc, City of Boston, IPG Photonics Corporation, CIRCOR International, OneSpan, & Emerson Health. The prestigious ORBIE Awards - hosted by BostonCIO, a chapter of the Inspire Leadership Network - honor CIOs who drive business transformation and make a lasting impact on the industry. Winners were recognized across eight categories: Super Global, Global, Large Enterprise, Enterprise, Large Corporate, Corporate, Nonprofit and Leadership. The ceremony, which took place at the Westin Boston Seaport, brought together top executives and industry leaders to celebrate excellence in technology leadership. 'Great CIOs understand how connections drive transformation,' said Lee Anne Howe, BostonCIO Chair. 'The ORBIE® Awards recognize CIOs who leverage relationships to drive innovation, solve complex challenges, and shape the future of Boston.' Meet the 2025 BostonCIO ORBIE Award Winners: Kathy Kountze, VP & Global CIO, Bose Corporation, received the Leadership ORBIE. Dr. Besufekad Alemayehu, SVP, Digital Manufacturing and Supply, received the Super Global ORBIE for organizations over $27 billion annual revenue and multi-national operations. Madhuri Andrews, EVP & CIO, MKS Instruments, Inc, received the Global ORBIE for organizations over $1 billion annual revenue and multi-national operations. Santiago Garces, CIO, City of Boston, received the Large Enterprise ORBIE for organizations over $3 billion annual revenue. Mark DeLorenzo, Sr. Director of Global Information Technology, IPG Photonics Corporation, received the Enterprise ORBIE for organizations over $1 billion annual revenue. Krishna Kashyap, SVP & CIO, CIRCOR International, received the Large Corporate ORBIE for organizations over $500 million annual revenue. Mike Lillie, CIO, OneSpan, received the Corporate ORBIE for organizations up to $500 million annual revenue. Renee Fosberg, SVP, CDO & CIO, Emerson Health, received the Nonprofit ORBIE for government, education, and nonprofit organizations. About the ORBIE: The ORBIE is the preeminent executive recognition for C-suite leaders. Since 1998, the ORBIE Awards have recognized leadership excellence, building relationships between executives and trusted business partners, and inspiring the next generation of executives. Finalists and winners are selected through an independent peer-adjudicated process led by prior ORBIE recipients based on the following criteria: Leadership and management effectiveness Business value created by technology innovation Engagement in industry and community endeavors BostonCIO ORBIE Keynote & Attendance: The keynote address for the BostonCIO ORBIE Awards was delivered by Kathy Kountze, VP & Global CIO of Bose Corporation, who was interviewed by Anne Margulies, VP & CIO (ret) of Harvard University. Over 450 guests attended, representing leading New England organizations and their technology partners. The following sponsors made the 2025 BostonCIO ORBIE Awards possible: Underwriters: BGSF, Markley Group, & Slalom Gold Sponsors: Comcast Business, Deloitte, EchoStor Technologies, Fortinet, Future Tech Enterprise, Kyndryl, & West Monroe Partners Silver Sponsors: Amazon Web Services, Cloudflare, Moveworks, Nasuni, Nerdio, Nutanix, Palto Alto Networks, T-Mobile, Tata Consultancy Services, Veeam Software, Veridas, Webex, & Zscaler Bronze Sponsors: Agilysys, Aqueduct Technologies, Between Pixels, Blue Mantis, ContractPodAI, EY, Island, Redesign, Virtusa Corporation, WEI, Wiz Media Partner: Boston Business Journal National Partner: YearUp United To learn more about sponsorship opportunities and how to connect with leading C-suite executives across North America, click here. About BostonCIO: BostonCIO is the preeminent peer leadership network of chief information officers (CIOs) in New England. As one of over 40 chapters of the Inspire Leadership Network, BostonCIO belongs to a national membership organization exclusively comprised of C-suite leaders from public and private businesses, government, education, healthcare, and nonprofit institutions. BostonCIO is led by a CIO Advisory Board, with support from an executive director and staff. Underwriter executives support the chapter and ensure the programs remain non-commercial and exclusive to qualified CIOs and members. About Inspire Leadership Network: Inspire Leadership Network is the preeminent peer leadership network of C-suite executives. With nearly 2,000 members across more than 40 local chapters, Inspire members serve public and private businesses, government, education, healthcare, and non-profit institutions. Inspire exists to help leaders thrive in today's most challenging executive roles. Media ContactNicole A photo accompanying this announcement is available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
16-05-2025
- Business
- Yahoo
We Think MKS Instruments' (NASDAQ:MKSI) Healthy Earnings Might Be Conservative
Shareholders appeared to be happy with MKS Instruments, Inc.'s (NASDAQ:MKSI) solid earnings report last week. Looking deeper at the numbers, we found several encouraging factors beyond the headline profit numbers. Our free stock report includes 4 warning signs investors should be aware of before investing in MKS Instruments. Read for free now. To properly understand MKS Instruments' profit results, we need to consider the US$82m expense attributed to unusual items. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And, after all, that's exactly what the accounting terminology implies. If MKS Instruments doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year. That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates. Because unusual items detracted from MKS Instruments' earnings over the last year, you could argue that we can expect an improved result in the current quarter. Based on this observation, we consider it likely that MKS Instruments' statutory profit actually understates its earnings potential! And one can definitely find a positive in the fact that it made a profit this year, despite losing money last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. If you want to do dive deeper into MKS Instruments, you'd also look into what risks it is currently facing. For instance, we've identified 4 warning signs for MKS Instruments (1 can't be ignored) you should be familiar with. This note has only looked at a single factor that sheds light on the nature of MKS Instruments' profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10-05-2025
- Business
- Yahoo
MKS Instruments, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
It's been a good week for MKS Instruments, Inc. (NASDAQ:MKSI) shareholders, because the company has just released its latest quarterly results, and the shares gained 5.6% to US$80.05. Revenues were US$936m, approximately in line with expectations, although statutory earnings per share (EPS) performed substantially better. EPS of US$0.77 were also better than expected, beating analyst predictions by 15%. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Taking into account the latest results, the consensus forecast from MKS Instruments' 13 analysts is for revenues of US$3.77b in 2025. This reflects a credible 3.1% improvement in revenue compared to the last 12 months. Per-share earnings are expected to increase 4.1% to US$3.50. Before this earnings report, the analysts had been forecasting revenues of US$3.79b and earnings per share (EPS) of US$4.13 in 2025. So there's definitely been a decline in sentiment after the latest results, noting the substantial drop in new EPS forecasts. Check out our latest analysis for MKS Instruments The average price target fell 6.1% to US$114, with reduced earnings forecasts clearly tied to a lower valuation estimate. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. There are some variant perceptions on MKS Instruments, with the most bullish analyst valuing it at US$160 and the most bearish at US$85.00 per share. Note the wide gap in analyst price targets? This implies to us that there is a fairly broad range of possible scenarios for the underlying business. Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. It's pretty clear that there is an expectation that MKS Instruments' revenue growth will slow down substantially, with revenues to the end of 2025 expected to display 4.1% growth on an annualised basis. This is compared to a historical growth rate of 12% over the past five years. Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 16% annually. So it's pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than MKS Instruments. The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for MKS Instruments. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that MKS Instruments' revenue is expected to perform worse than the wider industry. The consensus price target fell measurably, with the analysts seemingly not reassured by the latest results, leading to a lower estimate of MKS Instruments' future valuation. With that in mind, we wouldn't be too quick to come to a conclusion on MKS Instruments. Long-term earnings power is much more important than next year's profits. We have forecasts for MKS Instruments going out to 2027, and you can see them free on our platform here. You still need to take note of risks, for example - MKS Instruments has 4 warning signs (and 1 which makes us a bit uncomfortable) we think you should know about. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
09-05-2025
- Business
- Yahoo
MKS Instruments First Quarter 2025 Earnings: Beats Expectations
Revenue: US$936.0m (up 7.8% from 1Q 2024). Net income: US$52.0m (up 247% from 1Q 2024). Profit margin: 5.6% (up from 1.7% in 1Q 2024). EPS: US$0.77 (up from US$0.22 in 1Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) also surpassed analyst estimates by 15%. Looking ahead, revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Semiconductor industry in the US. Performance of the American Semiconductor industry. The company's shares are up 7.9% from a week ago. We should say that we've discovered 4 warning signs for MKS Instruments (1 is significant!) that you should be aware of before investing here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
